These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3039175)

  • 1. Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).
    Montalvo EA; Grose C
    J Virol; 1987 Sep; 61(9):2877-84. PubMed ID: 3039175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).
    Montalvo EA; Grose C
    Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.
    Montalvo EA; Parmley RT; Grose C
    J Virol; 1985 Mar; 53(3):761-70. PubMed ID: 2983087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a human cytomegalovirus glycoprotein complex (gcI).
    Gretch DR; Gehrz RC; Stinski MF
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1205-15. PubMed ID: 2838571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus.
    Keller PM; Davison AJ; Lowe RS; Bennett CD; Ellis RW
    Virology; 1986 Jul; 152(1):181-91. PubMed ID: 3012867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.
    el Battari A; Forget P; Fouchier F; Pic P
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):527-33. PubMed ID: 1654885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the role of glycans for the biological activity of Semliki Forest virus grown in Aedes albopictus cells using inhibitors of asparagine-linked oligosaccharides trimming.
    Naim HY; Koblet H
    Arch Virol; 1988; 102(1-2):73-89. PubMed ID: 2973779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of swainsonine and castanospermine on the sulfation of the oligosaccharide chains of N-linked glycoproteins.
    Merkle RK; Elbein AD; Heifetz A
    J Biol Chem; 1985 Jan; 260(2):1083-9. PubMed ID: 3918027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.
    Litwin V; Jackson W; Grose C
    J Virol; 1992 Jun; 66(6):3643-51. PubMed ID: 1316474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles.
    Repp R; Tamura T; Boschek CB; Wege H; Schwarz RT; Niemann H
    J Biol Chem; 1985 Dec; 260(29):15873-9. PubMed ID: 2999142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the biosynthesis and processing of N-linked oligosaccharides.
    Elbein AD
    CRC Crit Rev Biochem; 1984; 16(1):21-49. PubMed ID: 6232113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of N-linked oligosaccharide processing does not prevent the secretion of thyroglobulin. A study with swainsonine and deoxynojirimycin.
    Franc JL; Hovsepian S; Fayet G; Bouchilloux S
    Eur J Biochem; 1986 May; 157(1):225-32. PubMed ID: 2940087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic and structural studies on Thy-1 in a rat neuronal tumor cell line.
    Wilkerson LS; Touster O
    Arch Biochem Biophys; 1993 Jun; 303(2):238-45. PubMed ID: 8099781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2.
    Balachandran N; Hutt-Fletcher LM
    J Virol; 1985 Jun; 54(3):825-32. PubMed ID: 2987534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor.
    Litwin V; Sandor M; Grose C
    Virology; 1990 Sep; 178(1):263-72. PubMed ID: 2167554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.
    Keller PM; Lonergan K; Neff BJ; Morton DA; Ellis RW
    J Virol Methods; 1986 Sep; 14(2):177-88. PubMed ID: 3021804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for attachment of fatty acid to varicella-zoster virus glycoproteins and effect of cerulenin on the maturation of varicella-zoster virus glycoproteins.
    Namazue J; Kato T; Okuno T; Shiraki K; Yamanishi K
    Intervirology; 1989; 30(5):268-77. PubMed ID: 2551842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycosylation inhibitors on the structure and function of the murine transferrin receptor.
    Ralton JE; Jackson HJ; Zanoni M; Gleeson PA
    Eur J Biochem; 1989 Dec; 186(3):637-47. PubMed ID: 2514095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tunicamycin and N-linked oligosaccharide-processing inhibitors on the morphology of cultured porcine thyroid cells.
    Giraud A; Franc JL
    Eur J Cell Biol; 1989 Feb; 48(1):128-34. PubMed ID: 2526017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein.
    Grose C; Edwards DP; Weigle KA; Friedrichs WE; McGuire WL
    Virology; 1984 Jan; 132(1):138-46. PubMed ID: 6320530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.